Eric R Sokol, MD
Obstetrics/Gynecology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 18
- 4 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
18 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sokol’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
18 of 18 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A92783 · Current
Licensed to practise in California · since 2005 · expires 2027-01-31 · Wayne State University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$77,136
Medicare paid this office $77,136 for 326 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 104 | $9,635 | $80 |
| Creation of sling around urethra in female to control leakage | 13 | $8,576 | $660 |
| New patient visit (45+ min) | 90 | $8,209 | $91 |
| New patient visit (60+ min) | 46 | $7,045 | $153 |
| Injection of implant material beneath lining of bladder and/or urethra using an endoscope | 18 | $3,822 | $147 |
See all 12 services
| Return visit (30+ min) | 104 | $9,635 | $80 |
| Creation of sling around urethra in female to control leakage | 13 | $8,576 | $660 |
| New patient visit (45+ min) | 90 | $8,209 | $91 |
| New patient visit (60+ min) | 46 | $7,045 | $153 |
| Injection of implant material beneath lining of bladder and/or urethra using an endoscope | 18 | $3,822 | $147 |
| Short return visit (20+ min) | 51 | $3,558 | $53 |
| New patient visit (30+ min) | 34 | $3,161 | $93 |
| New patient visit (45+ min) | 18 | $2,634 | $146 |
| Fitting and insertion of vaginal support device | 41 | $1,921 | $36 |
| Short return visit (20+ min) | 19 | $1,762 | $73 |
| Long return visit (40+ min) | 11 | $1,439 | $131 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 11 | $1,354 | $113 |
Procedures Medicare counted
| Removal of the uterus | 1-10 | None |
Who their Medicare patients are
326 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 12% · Also on Medicaid 22% · Health risk score 0.95. Above the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 61% · Diabetes 24% · Coronary heart disease 17% · Cancer 17% · Depression 17% · Chronic kidney disease 15% · Stroke 10% · Heart failure 9% · COPD 9% · Atrial fibrillation 9% · Dementia 5%.
The office billed $473,762, Medicare allowed $104,739 and paid $77,136; for 585 services of 27 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 326 | 585 | 75 | 0.95 | $473,762 | $77,136 |
| 2023 | 226 | 401 | 74 | 1.18 | $273,590 | $50,937 |
| 2022 | 218 | 412 | 73 | 1.04 | $334,390 | $55,783 |
| 2021 | 262 | 541 | 74 | 1.04 | $388,912 | $80,278 |
| 2020 | 166 | 274 | 74 | 1.16 | $204,695 | $34,756 |
| 2019 | 238 | 468 | 74 | 1.14 | $270,587 | $56,585 |
| 2018 | 190 | 415 | 73 | 1.08 | $268,339 | $50,070 |
| 2017 | 162 | 327 | 73 | 1.13 | $245,590 | $44,694 |
| 2016 | 183 | 344 | 73 | 0.99 | $261,561 | $47,280 |
| 2015 | 188 | 439 | 74 | 1.07 | $388,478 | $65,642 |
| 2014 | 207 | 509 | 75 | 1.00 | $343,055 | $64,789 |
| 2013 | 237 | 585 | 74 | 0.97 | $444,855 | $78,203 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| New patient visit (60+ min) | 47 | $6,136 | $131 |
| Return visit (30+ min) | 63 | $5,984 | $82 |
| New patient visit (45+ min) | 49 | $5,362 | $109 |
| Short return visit (20+ min) | 54 | $4,392 | $55 |
| Injection of implant material beneath lining of bladder and/or urethra using an endoscope | 16 | $3,149 | $157 |
| Long return visit (40+ min) | 24 | $3,025 | $126 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 15 | $1,604 | $100 |
| Fitting and insertion of vaginal support device | 25 | $846 | $31 |
2022: 6 services
| New patient visit (60+ min) | 65 | $10,165 | $156 |
| Return visit (30+ min) | 59 | $4,889 | $76 |
| Short return visit (20+ min) | 59 | $4,641 | $56 |
| Long return visit (40+ min) | 28 | $3,462 | $112 |
| New patient visit (45+ min) | 23 | $2,589 | $113 |
| Fitting and insertion of vaginal support device | 36 | $1,105 | $26 |
2021: 13 services
| New patient visit (60+ min) | 55 | $9,210 | $167 |
| Return visit (30+ min) | 84 | $8,187 | $81 |
| Creation of sling around urethra in female to control leakage | 13 | $7,751 | $596 |
| Repair of pelvic ligaments through vagina | 12 | $5,976 | $498 |
| New patient visit (60+ min) | 34 | $5,715 | $168 |
| Repair of bladder hernia into vaginal wall | 11 | $4,930 | $448 |
| New patient visit (45+ min) | 37 | $4,091 | $111 |
| Long return visit (40+ min) | 32 | $3,989 | $121 |
| Short return visit (20+ min) | 41 | $2,879 | $54 |
| New patient visit (45+ min) | 16 | $1,483 | $93 |
| Long return visit (40+ min) | 11 | $1,281 | $116 |
| Return visit (30+ min) | 13 | $1,076 | $77 |
| Fitting and insertion of vaginal support device | 29 | $821 | $25 |
2020: 7 services
| Return visit (30+ min) | 56 | $4,617 | $65 |
| New patient visit (60+ min) | 27 | $3,925 | $145 |
| New patient visit (45+ min) | 28 | $3,090 | $110 |
| Long return visit (40+ min) | 17 | $1,664 | $92 |
| Short return visit (20+ min) | 25 | $857 | $31 |
| New patient visit (30+ min) | 12 | $840 | $70 |
| Fitting and insertion of vaginal support device | 16 | $405 | $25 |
2019: 8 services
| New patient visit (60+ min) | 46 | $6,753 | $147 |
| Return visit (30+ min) | 88 | $6,386 | $63 |
| New patient visit (45+ min) | 29 | $3,253 | $112 |
| Short return visit (20+ min) | 52 | $2,865 | $39 |
| Long return visit (40+ min) | 28 | $2,816 | $101 |
| New patient visit (30+ min) | 23 | $1,382 | $60 |
| Fitting and insertion of vaginal support device | 35 | $1,252 | $32 |
| Simple insertion of temporary bladder tube | 11 | $254 | $23 |
2018: 8 services
| Return visit (30+ min) | 67 | $6,146 | $68 |
| Repair of bladder hernia into vaginal wall | 11 | $5,053 | $459 |
| New patient visit (30+ min) | 71 | $4,209 | $59 |
| Short return visit (20+ min) | 48 | $2,447 | $38 |
| New patient visit (60+ min) | 15 | $2,114 | $141 |
| Fitting and insertion of vaginal support device | 32 | $1,552 | $39 |
| New patient visit (45+ min) | 14 | $1,368 | $98 |
| Simple insertion of temporary bladder tube | 11 | $232 | $21 |
2017: 8 services
| Creation of sling around urethra in female to control leakage | 13 | $6,815 | $524 |
| Repair of bladder hernia into vaginal wall | 11 | $4,839 | $440 |
| Return visit (30+ min) | 61 | $4,533 | $62 |
| Short return visit (20+ min) | 45 | $2,221 | $41 |
| New patient visit (30+ min) | 34 | $2,129 | $63 |
| New patient visit (45+ min) | 22 | $2,087 | $95 |
| New patient visit (60+ min) | 11 | $1,367 | $124 |
| Fitting and insertion of vaginal support device | 17 | $791 | $40 |
2016: 7 services
| Return visit (30+ min) | 62 | $4,811 | $63 |
| New patient visit (60+ min) | 22 | $3,164 | $144 |
| Short return visit (20+ min) | 43 | $2,142 | $40 |
| New patient visit (45+ min) | 22 | $1,926 | $88 |
| Long return visit (40+ min) | 17 | $1,822 | $91 |
| New patient visit (30+ min) | 30 | $1,695 | $57 |
| Fitting and insertion of vaginal support device | 26 | $1,032 | $36 |
2015: 11 services
| Repair of bulging of rectum and bladder into vaginal wall | 15 | $12,209 | $814 |
| Creation of sling around urethra in female to control leakage | 19 | $8,716 | $459 |
| Removal of uterus through vagina, 250.0 g or less | 12 | $7,078 | $590 |
| New patient visit (60+ min) | 46 | $6,371 | $138 |
| Return visit (30+ min) | 67 | $4,738 | $64 |
| New patient visit (45+ min) | 31 | $3,331 | $107 |
| Short return visit (20+ min) | 55 | $3,048 | $40 |
| Long return visit (40+ min) | 19 | $1,945 | $97 |
| Fitting and insertion of vaginal support device | 32 | $1,418 | $38 |
| Simple insertion of temporary bladder tube | 26 | $717 | $28 |
| Insertion of temporary bladder tube | 14 | $349 | $23 |
2014: 12 services
| Repair of bulging of rectum and bladder into vaginal wall | 13 | $10,452 | $804 |
| Creation of sling around urethra in female to control leakage | 15 | $8,214 | $548 |
| Return visit (30+ min) | 88 | $6,383 | $64 |
| New patient visit (60+ min) | 41 | $5,368 | $131 |
| New patient visit (45+ min) | 31 | $3,123 | $101 |
| Short return visit (20+ min) | 58 | $2,906 | $36 |
| Long return visit (40+ min) | 25 | $2,649 | $91 |
| Diagnostic exam of bladder and urethra using an endoscope | 20 | $1,705 | $85 |
| Fitting and insertion of vaginal support device | 28 | $1,196 | $41 |
| Simple insertion of temporary bladder tube | 31 | $882 | $28 |
| New patient visit (30+ min) | 11 | $743 | $68 |
| Insertion of temporary bladder tube | 19 | $448 | $24 |
2013: 15 services
| Surgical repair of vaginal defect using an endoscope | 13 | $10,738 | $826 |
| Repair of bulging of rectum and bladder into vaginal wall | 12 | $9,680 | $807 |
| Creation of sling around urethra in female to control leakage | 19 | $8,153 | $429 |
| New patient visit (60+ min) | 53 | $7,181 | $135 |
| Repair of herniated rectum into vaginal wall | 15 | $5,858 | $391 |
| Return visit (30+ min) | 80 | $5,328 | $58 |
| New patient visit (45+ min) | 39 | $4,172 | $107 |
| Short return visit (20+ min) | 58 | $3,119 | $39 |
| Diagnostic exam of bladder and urethra using an endoscope | 22 | $1,698 | $71 |
| Long return visit (40+ min) | 20 | $1,631 | $82 |
| Fitting and insertion of vaginal support device | 39 | $1,587 | $38 |
| New patient visit (30+ min) | 21 | $1,385 | $66 |
| Simple insertion of temporary bladder tube | 45 | $1,198 | $27 |
| Insertion of temporary bladder tube | 22 | $509 | $23 |
| Short return visit | 18 | $264 | $13 |
Medicaid work
$587 in 2023
Medicaid paid $587 for 26 billed services this clinician did in 2023, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 13 | $393 |
| Short return visit (20+ min) | 13 | $194 |
| 2023 | 26 | 2 | 13 | $587 |
Drugs they prescribed that Part D paid
$69,967
Pharmacies billed $69,967 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 211) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
125 generic and 86 brand-name prescriptions · $69,967 in drug cost · 20 antibiotic prescriptions to 18 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 36 | $34,352 | $954 |
| Gemtesa | 22 | $18,309 | $832 |
| Premarin | 23 | $9,898 | $430 |
| Estradiol | 103 | $6,280 | $61 |
Year by year
| 2024 | 211 | 104 | 0% (0) | 41% | $69,967 |
| 2023 | 129 | 61 | 0% (0) | 56% | $58,361 |
| 2022 | 89 | 48 | 0% (0) | 62% | $38,844 |
| 2021 | 104 | 46 | 0% (0) | 50% | $31,975 |
| 2020 | 120 | 44 | 0% (0) | 46% | $40,841 |
| 2019 | 241 | 89 | 0% (0) | 44% | $66,799 |
| 2018 | 283 | 87 | None | 48% | $69,788 |
| 2017 | 234 | 82 | 0% (0) | 50% | $51,427 |
| 2016 | 171 | 72 | 0% (0) | 46% | $30,784 |
| 2015 | 152 | 58 | None | 50% | $21,311 |
| 2014 | 177 | 71 | 13% (23) | 41% | $19,381 |
| 2013 | 205 | 70 | None | 44% | $23,350 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Myrbetriq | 51 | $41,115 | $806 |
| Estradiol | 43 | $4,175 | $97 |
2022: 3 drugs
| Myrbetriq | 22 | $23,813 | $1,082 |
| Premarin | 30 | $10,978 | $366 |
| Estradiol | 20 | $2,281 | $114 |
2021: 4 drugs
| Myrbetriq | 26 | $20,412 | $785 |
| Premarin | 21 | $8,033 | $383 |
| Estradiol | 16 | $2,382 | $149 |
| Nitrofurantoin Mono-Macro | 12 | $145 | $12 |
2020: 3 drugs
| Myrbetriq | 25 | $20,998 | $840 |
| Premarin | 30 | $11,802 | $393 |
| Estradiol | 23 | $4,501 | $196 |
2019: 6 drugs
| Myrbetriq | 50 | $33,977 | $680 |
| Premarin | 52 | $20,384 | $392 |
| Estradiol | 37 | $6,724 | $182 |
| Oxybutynin Chloride Er | 15 | $963 | $64 |
| Cephalexin | 19 | $145 | $8 |
| Ciprofloxacin | 17 | $112 | $7 |
2018: 9 drugs
| Premarin | 66 | $24,578 | $372 |
| Myrbetriq | 41 | $23,337 | $569 |
| Estrace | 15 | $6,691 | $446 |
| Estradiol | 21 | $5,451 | $260 |
| Detrol La | 11 | $4,106 | $373 |
| Oxybutynin Chloride Er | 40 | $2,899 | $72 |
| Nitrofurantoin Mono-Macro | 15 | $370 | $25 |
| Ciprofloxacin | 16 | $141 | $9 |
| Ibuprofen | 11 | $47 | $4 |
2017: 6 drugs
| Premarin | 61 | $21,052 | $345 |
| Myrbetriq | 30 | $15,857 | $529 |
| Estrace | 18 | $5,459 | $303 |
| Detrol La | 11 | $3,946 | $359 |
| Oxybutynin Chloride Er | 47 | $2,740 | $58 |
| Cephalexin | 12 | $50 | $4 |
2016: 6 drugs
| Premarin | 44 | $14,349 | $326 |
| Myrbetriq | 22 | $11,532 | $524 |
| Oxybutynin Chloride Er | 42 | $2,511 | $60 |
| Nitrofurantoin Mono-Macro | 17 | $299 | $18 |
| Ciprofloxacin | 11 | $200 | $18 |
| Ibuprofen | 12 | $47 | $4 |
2015: 7 drugs
| Premarin | 33 | $8,798 | $267 |
| Myrbetriq | 17 | $6,148 | $362 |
| Detrol La | 12 | $3,353 | $279 |
| Oxybutynin Chloride Er | 17 | $1,245 | $73 |
| Ciprofloxacin | 19 | $238 | $13 |
| Nitrofurantoin Mono-Macro | 16 | $232 | $15 |
| Ibuprofen | 14 | $52 | $4 |
2014: 6 drugs
| Premarin | 35 | $7,626 | $218 |
| Detrol La | 13 | $3,138 | $241 |
| Oxybutynin Chloride Er | 19 | $1,526 | $80 |
| Nitrofurantoin Mono-Macro | 21 | $357 | $17 |
| Hydrocodone-Acetaminophen | 20 | $147 | $7 |
| Ibuprofen | 22 | $87 | $4 |
2013: 5 drugs
| Premarin | 51 | $10,314 | $202 |
| Detrol La | 29 | $6,197 | $214 |
| Oxybutynin Chloride Er | 32 | $2,573 | $80 |
| Nitrofurantoin Mono-Macro | 12 | $316 | $26 |
| Ibuprofen | 13 | $51 | $4 |
Money from drug and device companies
$273 in 2025
| 2025 | 1 | 2 | None | $273 |
| 2024 | 1 | 6 | None | $438 |
| 2023 | 2 | 5 | None | $631 |
| 2022 | 3 | 6 | None | $532 |
| 2021 | 1 | 1 | None | $37 |
| 2019 | 2 | 5 | None | $303 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Coloplast | Altis | $273 | 2 payments
|
See all 2 published payments
| Coloplast | Meals · 2025-10-17 | Altis | $125 |
| Coloplast | Meals · 2025-03-31 | Altis | $148 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $438
| Coloplast | Altis | $438 | 6 payments
|
2023: $631
| Coloplast | Titan | $450 | 3 payments
|
| Axonics | Axonics | $181 | 2 payments
|
2022: $532
| Coloplast | Altis | $220 | 2 payments
|
| Boston Scientific | Solyx Sis System | $218 | 2 payments
|
| Myovant Sciences | Myfembree | $95 | 2 payments
|
2021: $37
| Urocure | None | $37 | 1 payment
|
2019: $303
| Coloplast | Altis | $190 | 4 payments
|
| Caldera Medical | Desara | $113 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| ACELL, INC. · Pelvic Organ Prolapse · 2019 | Their institution | $5,663 |
| COLOPLAST CORP · Altis Single Incision Sling System Versus Transobturator Or Retropubic Mesh Slings in the Treatement of Stress Urinary Incontinence (Altis 522 Study) · 2021 | This clinician | $3,729 |
| Cook Research Incorporated · Use of the Zenith Dissection Endovascular System in the Treatment of Patients With Acute, Complicated Type B Aortic Dissec · 2019 | Their institution | $3,156 |
| Cook Research Incorporated · (13-003) A Double-Blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of Amdc-Usr With Placebo in Female Subjects With Stress Urinary Incontinence · 2020 | This clinician | $1,953 |
| Coloplast Corp · Restorelle · 2020 | This clinician | $1,895 |
| Cook Research Incorporated · Zenith P-Branch Endovascular Graft - Pivotal Study · 2019 | Their institution | $1,707 |
| Cook Research Incorporated · Cmi-Ind2: 13-003 Ind Study 2 - Female Su · 2020 | This clinician | $1,651 |
| Cook Research Incorporated · A Double-Blind, Randomized, Controlled Trial Comparing the Safety and Effic · 2019 | Their institution | $1,542 |
| Cook Research Incorporated · A Double-Blind, Randomized, Controlled Trial Com · 2019 | Their institution | $1,280 |
| COLOPLAST CORP · Restorelle Transvaginal Mesh Versus Native Tissue Repair for Treatment of Pelvic Organ Prolapse · 2021 | This clinician | $844 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1508911538
- Licence
- CA A92783California A92783: Current · expires 2027-01-31
- Trained
- Wayne State University School of Medicine, 1998
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207VF0040X (207VF0040X); Federal specialty code 207V00000X (207V00000X); Federal specialty code 207VG0400X (207VG0400X)
- Mailing address
- 300 Pasteur Dr, Room Hh333, Stanford, CA, 94305
- NPI first listed
- 2007-01-23
- NPI last updated
- 2024-04-26
- NPI record certified
- 2024-04-26
This is when the NPI record was last certified, not a medical board exam.